RUBICON price chart
Daily close · 5-year history
Instrument details
Identifiers & classification
- Symbol
- RUBICON
- MB Code
- MBEQU5889
- ISIN
- INE506V01022
- BSE code
- 544578
- Industry group
- Pharmaceuticals & Biotechnology
- Screener
- View peers →
Latest earnings
Most recent declared quarter
- Quarter
- Mar 2026
- Revenue
- 513.92 Cr
- Net profit
- 76.79 Cr
- EPS
- 4.6
- YoY revenue
- +43.49%
Company documents
10 PDFs across 4 categories
Audited annual reports & financial statements
Earnings call transcripts & Q&A
Investor decks & strategy updates
Exchange filings & corporate announcements
Corporate timeline
Earnings, news & corporate actions for RUBICON
Rubicon Research surged 15% to a 52-week high after strong Q4 FY26 results; revenue rose 44%, PAT more than doubled, and the board recomm…
Rubicon Research jumped 12.55% after reporting Q4 FY26 net profit doubled to Rs 76.78 crore and revenue rose 43.49% to Rs 513.91 crore.
Rubicon Research's stock rose 3.35% to Rs 748.20 following a significant 91.2% year-on-year increase in consolidated net profit to Rs 72.…
EPS 4.41 vs est. 3.88
Beat estimates by 13.78%
Investec has initiated coverage on Rubicon Research with a 'buy' rating, projecting a 47% EPS CAGR from FY25 to FY28. The firm highlights…
Rubicon Research Ltd saw its shares surge nearly 28% during its market debut, indicating strong investor interest. This significant jump …
Rubicon Research Ltd's IPO lists today, buoyed by a high grey market premium (GMP). The IPO was heavily subscribed, with NIIs at 97.61 ti…
Rubicon Research Ltd. will debut on October 16, 2025, after an oversubscribed IPO that closed on October 14, with a subscription rate of …
Price returns
Historical performance
Technicals
Indicator consensus